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Sunday, February 3, 2013 111aWe extend this kinetic analysis to include other cell lines, including MDCKII-
MDR1 (National Institute of Health) and Caco-2. Digoxin transport across
confluent cell monolayers was measured in the absence and presence of several
P-gp substrates and/or inhibitors. Our kinetic analysis showed that digoxin
transport in these other cell lines typically requires a basolateral digoxin uptake
transporter. The B>A transport inhibition curve of digoxin was a conflation of
inhibitor binding to both P-gp and to this basolateral digoxin uptake transporter.
If a new compound is an inhibitor of digoxin transport across any of these cell-
lines, the IC50 could be due to binding to P-gp or to the basolateral digoxin
uptake transporter, or both. Finally, our analysis allowed us to estimate the
efflux active P-gp surface density on the cell lines, which is the fraction of
P-gp in the plasma membrane which successfully effluxes substrate into the
apical chamber, which depends upon microvilli morphology.
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The work presented here introduces a strategy to kill selectively multidrug
resistant (MDR) cancer cells that express the ABCG2 transporter (also called
breast cancer resistance protein, BCRP). The approach is based on specific
stimulation of ATP hydrolysis by ABCG2 transporters with sub-toxic doses
of curcumin combined with stimulation of ATP hydrolysis by the Naþ Kþ
ATPase with sub-toxic doses of ouabain or gramicidin A. The resulting over-
consumption of ATP by both pathways inhibits the efflux activity of ABCG2
transporters and leads to depletion of intracellular ATP levels below the viabil-
ity threshold. In contrast, cells without the ABCG2 transporter lack one path-
way and maintain viability at basal ATP levels. Similar results were obtained
with a clinically relevant human breast adenocarcinoma cell line that expresses
ABCG2 transporters (MCF-7/FLV1) and its parental cell line (MCF-7). This
strategy, which is based on compounds that are currently in clinical use, ex-
ploits the overexpression of ABCG2 transporters in cancer cells by accelerating
their ATP hydrolysis rate to kill selectively those cells which are particularly
resistant to conventional chemotherapy. This work introduces a novel strategy
to exploit collateral sensitivity (CS) with a combination of two compounds that,
individually, do not exert CS. It also demostrates that the mechanism for CS is
necrotic cell death induced by depletion of ATP below 50% of basal intracel-
lular levels. Since ABCG2 transporters are a putative marker for cancer stem
cells (CSCs), this approach may allow targeting CSCs.
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P-glycoprotein (P-gp), a member of the ATP binding cassette (ABC) trans-
porter family, actively excludes chemotherapeutics leading to reduced efficacy
of these agents, and the phenomenon of multidrug resistance (MDR) in cancer
cells. Thus, development of functional assays to better characterize P-gp and
minimize MDR is important for cancer therapy. Previous report demonstrated
that efflux of gramicidin D, a pore-forming antibiotic peptide, by P-gp reduced
pore formation, resulting in decreased cellular accumulation of 86Rbþ. This re-
sult suggested that gramicidin D is a substrate of P-gp [1]. This work presented
here establishes a novel approach to monitor the efflux activity of P-gp directly
and in real time. This approach takes advantage of the single molecule sensitiv-
ity of patch clamp techniques to measure currents through pores of the ion
channel forming peptide, gramicidin A (gA), which is also a substrate of
P-gp. Therefore, changes in whole cell gA currents directly report the efflux
of gA by P-gp. For instance, parental cells that do not express P-gp show whole
cell gA currents in a dose dependent manner, whereas resistant cells that over-
express P-gp show significantly reduced gA currents. P-gp inhibitors restore gA
currents to the level comparable to that in parental cells, which provides the
ability to screen for competitive inhibitor of P-gp. In addition, this assay pro-
vides easy access to extracellular and intracellular solution, and direct control
of cell membrane potential and intracellular concentration of molecules such as
ATP and Ca2þ. Results demonstrate that membrane depolarization enhances
the activity of P-gp while hyperpolarization reduces P-gp activity.
Reference:
1.Assaraf, Y.G. and M.J. Borgnia, Probing the interaction of the multidrugre-
sistance phenotype with the polypeptide ionophore gramicidin D via functional
channel formation. Eur J Biochem, 1994. 222(3): p. 813-24.573-Pos Board B342
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The electrogenic Naþ-HCO3
 co-transporter NBCe1-B plays a crucial role in
pHin regulation and epithelial HCO3
 secretion by mediating basolateral
HCO3
 entry, when the luminal HCO3
 exit mediated by CFTR and members
of the SLC26 transporters.
The regulation of NBCe1-B is poorly understood. IRBIT, (inositol 1,4,5-tri-
sphosphate receptor binding protein released with IP3), binds to N terminus
of NBCe1-B to markedly increase its activity, while the WNK/SPAK pathway
setting the resting state by reducing surface expression of NBCe1-B. NBCe1-B
may also be regulated by PIP2 interacting with highly charge module in the N
terminus. The site and mechanisms for the regulation by IRBIT, PIP2, and
SPAK and the relationship between them are not known.
We identified a positive clustered module in NBCe1-B and three arginines
within required for regulation by IRBIT and PIP2. The effect of IRBIT and
PIP2 are not additive but complementary. The module contains two critical
phosphorylation sites. The constitutively cAMP phosphorylated Thr49 is re-
quired for all form of NBCe1-B regulations, while Ser65 mediates the function
of SPAK. The module is conserved in most NBC superfamily and have the
same roles in NBCn1-A. These findings suggest the sites of regulation on
NBCe1-B by IRBIT/PIP2 and SPAK and provide a molecular mechanism by
which these regulatory factors converge to coordinate epithelia HCO3

secretion.
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ATP-binding cassette (ABC) transporters couple the uphill transport of sub-
stances to the hydrolysis of ATP. Mutations in the E. coli maltose ABC trans-
porter have been isolated that allow transport in the absence of periplasmic
maltose binding protein (MBP), a protein that delivers maltose to the trans-
porter with high affinity and stimulates the ATPase activity of the transporter.
One such mutant, MalG511, shows an interesting biphasic behavior with low
levels of MBP stimulating transport activity while higher levels (>50mM)
inhibit transport activity. Remarkably, the rescuing effect of MBP suppressor
mutants isolated at high, inhibitory MBP concentrations provided insight into
regulatory mechanisms in the ABC transporter superfamily. Site directed
spin labeling EPR spectroscopy was used to follow the catalytic cycle of
MalG511 without any binding protein, with MBP and with suppressor MBP
by attaching spin label at two positions in the MalK ATPase subunit (V16
and R129) that can be used to detect the closure of nucleotide-binding interface.
MalG511 responded differently to the addition of ligands, including nucleotide
and MBP, than wild type transporter. Notably, MalG511 can sample all confor-
mational states (open, semi-open and closed interface) in the absence of MBP,
as expected for a MBP-independent transporter. However, the closed state
could be stabilized only in the presence of a transition state analogue (vanadate)
suggesting that the mutations in MalG511 altered the conformational equilib-
rium of the transporter, favoring a semi-open over a closed conformation,
even in the presence of ATP, plus or minus MBP. The addition of MBP, but
not suppressor MBP, also resulted in a failure of the transporter to return to
the fully open state at the end of a catalytic cycle, suggesting a mechanism
for inhibition of transport at high MBP concentration.
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Sodium dependent neutral amino acid transporter (SNAT) 2, a member of the
solute carrier (SLC) 38 family, system A, mediates the coupled transport of
sodium and small neutral amino acids across a cell’s membrane. There has
been proposed structural homology between SNAT2 and the sodium/betaine
symporter, BetP. We mutated two conserved amino acids that have been shown
